Cargando…

AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines

Background: The Appraisal of Guidelines Research and Evaluation (AGREE) II instrument has been widely used in the methodological quality assessment of clinical practice guidelines (CPG). Chinese medicine CPGs have unique characteristics which distinguish them from those of Western medicine, e.g. syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiuli, Wang, Yangyang, Li, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877221/
https://www.ncbi.nlm.nih.gov/pubmed/36712664
http://dx.doi.org/10.3389/fphar.2022.1057920
_version_ 1784878321935319040
author Xie, Xiuli
Wang, Yangyang
Li, Hui
author_facet Xie, Xiuli
Wang, Yangyang
Li, Hui
author_sort Xie, Xiuli
collection PubMed
description Background: The Appraisal of Guidelines Research and Evaluation (AGREE) II instrument has been widely used in the methodological quality assessment of clinical practice guidelines (CPG). Chinese medicine CPGs have unique characteristics which distinguish them from those of Western medicine, e.g. syndrome differentiation, on which treatments are based. As such, certain domains and items in AGREE II are unsuitable for assessing TCM CPGs. Therefore, it is necessary to adjust and supplement the description and rating section of some items of the AGREE Ⅱinstrument. Purpose: To adjust and expand AGREE II according to characteristics of TCM clinical practice guidelines. Methods: A research working group was established, consisting of a core working group and an expert consensus group, before a systematic literature search performed to screen for TCM guidelines. Two researchers evaluated the quality of the included guidelines using AGREE Ⅱ and later proposed adjustments to some items of AGREE Ⅱ and supplementary comments, which were applicable to TCM CPGs, and drafted an initial version of AGREE Ⅱ for TCM. Suggestions from literature on development and evaluation of TCM CPGs were solicited and integrated into the revised version, which 16 experts were then invited to advise on. When the experts reached a consensus, their comments to the draft were adopted by the core group into the final version. Results: After evaluating the included TCM guidelines, the two researchers offered adjustments and supplementary comments for AGREE Ⅱ Items 1, 7, 10, 11, 12, 15, and 18, and drafted an initial version of AGREE Ⅱ for TCM. Combining suggestions from the literature on development and quality evaluation of TCM clinical guidelines, the core working group modified AGREE Ⅱ items 2, 4, 5, 8, 9, 13, 20, and 21, then proposed the revised version of AGREE Ⅱ for TCM, on which was advised by a group of experts, before consensus on improvements was reached. The results of the first round of expert surveys showed strong agreement, and experts’ opinions were adopted into the final version of AGREE Ⅱ for TCM. Conclusion: Based on the characteristics of the TCM CPGs, we adjustment and expansion were made to create AGREE II for TCM. This version is suitable for the assessment of methodological quality of TCM CPGs, capable of providing content support for the standardization of procedures and methods of formulating TCM CPGs.
format Online
Article
Text
id pubmed-9877221
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98772212023-01-27 AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines Xie, Xiuli Wang, Yangyang Li, Hui Front Pharmacol Pharmacology Background: The Appraisal of Guidelines Research and Evaluation (AGREE) II instrument has been widely used in the methodological quality assessment of clinical practice guidelines (CPG). Chinese medicine CPGs have unique characteristics which distinguish them from those of Western medicine, e.g. syndrome differentiation, on which treatments are based. As such, certain domains and items in AGREE II are unsuitable for assessing TCM CPGs. Therefore, it is necessary to adjust and supplement the description and rating section of some items of the AGREE Ⅱinstrument. Purpose: To adjust and expand AGREE II according to characteristics of TCM clinical practice guidelines. Methods: A research working group was established, consisting of a core working group and an expert consensus group, before a systematic literature search performed to screen for TCM guidelines. Two researchers evaluated the quality of the included guidelines using AGREE Ⅱ and later proposed adjustments to some items of AGREE Ⅱ and supplementary comments, which were applicable to TCM CPGs, and drafted an initial version of AGREE Ⅱ for TCM. Suggestions from literature on development and evaluation of TCM CPGs were solicited and integrated into the revised version, which 16 experts were then invited to advise on. When the experts reached a consensus, their comments to the draft were adopted by the core group into the final version. Results: After evaluating the included TCM guidelines, the two researchers offered adjustments and supplementary comments for AGREE Ⅱ Items 1, 7, 10, 11, 12, 15, and 18, and drafted an initial version of AGREE Ⅱ for TCM. Combining suggestions from the literature on development and quality evaluation of TCM clinical guidelines, the core working group modified AGREE Ⅱ items 2, 4, 5, 8, 9, 13, 20, and 21, then proposed the revised version of AGREE Ⅱ for TCM, on which was advised by a group of experts, before consensus on improvements was reached. The results of the first round of expert surveys showed strong agreement, and experts’ opinions were adopted into the final version of AGREE Ⅱ for TCM. Conclusion: Based on the characteristics of the TCM CPGs, we adjustment and expansion were made to create AGREE II for TCM. This version is suitable for the assessment of methodological quality of TCM CPGs, capable of providing content support for the standardization of procedures and methods of formulating TCM CPGs. Frontiers Media S.A. 2023-01-12 /pmc/articles/PMC9877221/ /pubmed/36712664 http://dx.doi.org/10.3389/fphar.2022.1057920 Text en Copyright © 2023 Xie, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xie, Xiuli
Wang, Yangyang
Li, Hui
AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title_full AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title_fullStr AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title_full_unstemmed AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title_short AGREE II for TCM: Tailored to evaluate methodological quality of TCM clinical practice guidelines
title_sort agree ii for tcm: tailored to evaluate methodological quality of tcm clinical practice guidelines
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877221/
https://www.ncbi.nlm.nih.gov/pubmed/36712664
http://dx.doi.org/10.3389/fphar.2022.1057920
work_keys_str_mv AT xiexiuli agreeiifortcmtailoredtoevaluatemethodologicalqualityoftcmclinicalpracticeguidelines
AT wangyangyang agreeiifortcmtailoredtoevaluatemethodologicalqualityoftcmclinicalpracticeguidelines
AT lihui agreeiifortcmtailoredtoevaluatemethodologicalqualityoftcmclinicalpracticeguidelines